JP2021532176A5 - - Google Patents
Info
- Publication number
- JP2021532176A5 JP2021532176A5 JP2021524129A JP2021524129A JP2021532176A5 JP 2021532176 A5 JP2021532176 A5 JP 2021532176A5 JP 2021524129 A JP2021524129 A JP 2021524129A JP 2021524129 A JP2021524129 A JP 2021524129A JP 2021532176 A5 JP2021532176 A5 JP 2021532176A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- seq
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697939P | 2018-07-13 | 2018-07-13 | |
| US62/697,939 | 2018-07-13 | ||
| PCT/IB2019/000720 WO2020012244A2 (en) | 2018-07-13 | 2019-07-11 | Treating ulcerative colitis with brazikumab |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532176A JP2021532176A (ja) | 2021-11-25 |
| JP2021532176A5 true JP2021532176A5 (enExample) | 2022-08-15 |
Family
ID=68072845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524129A Pending JP2021532176A (ja) | 2018-07-13 | 2019-07-11 | ブラジクマブによる潰瘍性大腸炎の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210277105A1 (enExample) |
| EP (1) | EP3820897A2 (enExample) |
| JP (1) | JP2021532176A (enExample) |
| KR (1) | KR20210032441A (enExample) |
| CN (1) | CN112689643A (enExample) |
| AU (1) | AU2019300491A1 (enExample) |
| CA (1) | CA3105598A1 (enExample) |
| EA (1) | EA202190197A1 (enExample) |
| IL (1) | IL279917A (enExample) |
| SG (1) | SG11202100185VA (enExample) |
| WO (1) | WO2020012244A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| CN111718414B (zh) * | 2020-06-12 | 2021-03-02 | 江苏荃信生物医药有限公司 | 抗人白介素23单克隆抗体及其应用 |
| AU2023383916A1 (en) * | 2022-11-22 | 2025-07-10 | Janssen Biotech, Inc. | Method of treating ulcerative colitis with anti-il23 specific antibody |
| WO2025170982A2 (en) | 2024-02-06 | 2025-08-14 | Paragon Therapeutics, Inc. | Il-23 antibody compositions and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| ZA986596B (en) | 1997-07-25 | 1999-02-08 | Schering Corp | Mammalian cytokine related reagents |
| SI2452694T1 (sl) | 2005-06-30 | 2019-05-31 | Janssen Biotech, Inc. | Protitelesa proti-IL-23, sestavki in postopki uporabe |
| DE602006015830D1 (de) | 2005-08-25 | 2010-09-09 | Lilly Co Eli | Anti-il-23-antikörper |
| PT1931710T (pt) | 2005-08-31 | 2017-03-28 | Merck Sharp & Dohme | Anticorpos anti-il-23 manipulados |
| HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-IL-23 antibodies, preparations, methods and applications |
| US7790862B2 (en) | 2006-06-13 | 2010-09-07 | Zymogenetics, Inc. | IL-17 and IL-23 antagonists and methods of using the same |
| ES2708988T3 (es) | 2007-02-23 | 2019-04-12 | Merck Sharp & Dohme | Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética |
| JP2010518858A (ja) | 2007-02-23 | 2010-06-03 | シェーリング コーポレイション | 操作された抗−ｉｌ−２３ｐ１９抗体 |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| EP2331078B1 (en) | 2008-08-27 | 2012-09-19 | Merck Sharp & Dohme Corp. | Lyophilized formulations of engineered anti-il-23p19 antibodies |
| US20120128689A1 (en) | 2009-04-01 | 2012-05-24 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| US20120264917A1 (en) | 2009-05-27 | 2012-10-18 | Ablynx N.V. | Biparatopic protein constructs directed against il-23 |
| JO3244B1 (ar) * | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| WO2012009760A1 (en) | 2010-07-20 | 2012-01-26 | Cephalon Australia Pty Ltd | Anti-il-23 heterodimer specific antibodies |
| MX2019000046A (es) | 2010-11-04 | 2023-10-05 | Boehringer Ingelheim Int | Anticuerpos anti-il-23. |
| SG11201507483PA (en) * | 2013-03-15 | 2015-10-29 | Amgen Inc | Methods for treating crohn's disease using an anti-il23 antibody |
-
2019
- 2019-07-11 CN CN201980046566.9A patent/CN112689643A/zh active Pending
- 2019-07-11 US US17/259,448 patent/US20210277105A1/en not_active Abandoned
- 2019-07-11 CA CA3105598A patent/CA3105598A1/en active Pending
- 2019-07-11 EA EA202190197A patent/EA202190197A1/ru unknown
- 2019-07-11 JP JP2021524129A patent/JP2021532176A/ja active Pending
- 2019-07-11 WO PCT/IB2019/000720 patent/WO2020012244A2/en not_active Ceased
- 2019-07-11 KR KR1020217004216A patent/KR20210032441A/ko not_active Ceased
- 2019-07-11 SG SG11202100185VA patent/SG11202100185VA/en unknown
- 2019-07-11 AU AU2019300491A patent/AU2019300491A1/en not_active Abandoned
- 2019-07-11 EP EP19779090.0A patent/EP3820897A2/en not_active Withdrawn
-
2021
- 2021-01-03 IL IL279917A patent/IL279917A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532176A5 (enExample) | ||
| JP2019523295A5 (enExample) | ||
| JP2022033868A5 (enExample) | ||
| JP2020500152A5 (enExample) | ||
| IL316408A (en) | A safe and effective method for treating psoriasis with a specific anti-IL23 antibody | |
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| JP2024001125A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2022188083A5 (enExample) | ||
| JP2023527542A5 (enExample) | ||
| JP2021502349A5 (enExample) | ||
| JP2020502261A5 (enExample) | ||
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| CN112689512B (zh) | 用于治疗银屑病的组合物和方法 | |
| JP2025503948A (ja) | 頭皮の尋常性乾癬を有する対象者の治療方法 | |
| JP2022536088A5 (enExample) | ||
| JP2021530697A5 (enExample) | ||
| JP2022529929A5 (enExample) | ||
| JP2021523138A5 (enExample) | ||
| JP2024512255A5 (enExample) | ||
| KR20180017145A (ko) | 소양증의 치료 | |
| JP2024542777A5 (enExample) | ||
| JP2022514561A5 (enExample) | ||
| JP2024543885A5 (enExample) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| JP2021533142A5 (enExample) |